Sign In
Buy MNOV
$1.36
+0.0600 (+4.62%)
At Close: Jun 23, 2026
The Daily Biotech Pulse: Amgen Hurt By Generic Competition, Nanoviricides Confirms Working On Wuhan Virus, Arcutis IPO
02:09pm, Friday, 31'st Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on Jan. 30)
Acceleron Pharma Inc (...
The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance
02:26pm, Thursday, 30'th Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 29) 10X Genomics Inc (NASDAQ: TXG ) Agile Therapeutics
The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics
12:12pm, Tuesday, 28'th Jan 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 27) 10X Genomics Inc (NASDAQ: TXG ) Achillion Pharmace
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs Dec. 24.) Aimmune Therapeutics Inc (NASDAQ: AIMT )
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that additional analyses
MediciNova Reports Added Analyses From Completed Trial Of MN-166 In ALS Presented At 30th Int'l. Symposium On ALS/MND
12:00am, Wednesday, 04'th Dec 2019We're Not Worried About MediciNova's (NASDAQ:MNOV) Cash Burn
05:57pm, Monday, 18'th Nov 2019
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
Here is What Hedge Funds Think About MediciNova, Inc. (MNOV)
06:50pm, Wednesday, 06'th Nov 2019
Is MediciNova, Inc. (NASDAQ:MNOV) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been sever
MNOV: Phase 3 Trial Initiated for MN-166 in ALS
11:00pm, Wednesday, 30'th Oct 2019
By David Bautz, PhD NASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT HERE Business Update Phase 3 Trial of MN-166 in ALS Underway In April 2019, MediciNova, Inc. (NASDAQ:MNOV) announced that following
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), today announced that it has received a Not
MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of NAFLD and NASH in Japan
10:00am, Wednesday, 23'rd Oct 2019
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that it has received
